Radiesse® Dermal Filler — Press Releases
Please view the press releases below to learn more about the significant news we have announced.
- January 11, 2007
RADIESSE® SURVEY FINDS OVER 22 MILLION U.S. WOMEN MORE APT TO USE A SAFE, LONGER-LASTING AND AFFORDABLE COSMETIC WRINKLE FILLER - December 27, 2006
FDA APPROVES RADIESSE FACIAL FILLER FOR TWO NEW AESTHETIC INDICATIONS: Long-Lasting Filler from BioForm Medical Approved for Treatment of Facial Wrinkles and Folds and for the Correction of HIV-Associated Facial Wasting - August 24, 2006
FDA ADVISORY PANEL RECOMMENDS APPROVAL OF RADIESSE® FOR TWO FACIAL AESTHETIC APPLICATIONS: General and Plastic Surgery Devices Advisory Panel Determines RADIESSE Safe and Effective in Correcting Facial Wrinkles and Folds and in the Restorative Treatment of HIV-Associated Facial Lipoatrophy - April 24, 2006
CLINICAL STUDY PROVES RADIESSE FACIAL FILLER DELIVERS LONGER LASTING CORRECTION OF NASOLABIAL FOLDS COMPARED TO RESTYLANE: Study Results Released at Aesthetic Plastic Surgery Conference in Orlando - November 10, 2005
RADIESSE RECEIVES FACIAL AESTHETICS APPROVAL IN CANADA: Leading Canadian Distributor, Canderm Pharma, Will Launch Radiesse To Plastic Surgeons And Dermatologists Seeking A Long-Lasting Non-Permanent Filler For Facial Aesthetics - November 8, 2005
RADIESSE NASOLABIAL FOLD TREATMENT MULTICENTER STUDY SUPPORTS FILING FOR U.S. AESTHETICS APPROVAL: Radiesse is a New Filler Designed to Provide a Longer Term Augmentation than Current Products - September 28, 2005
LANDMARK STUDY OF RADIESSE FINDS 100% OF PATIENTS REPORT SIGNIFICANT IMPROVEMENT IN APPEARANCE OF FACIAL WASTING AT 12-MONTHS FOLLOWING TREATMENT: BIOFORM MEDICAL TO FILE RADIESSE FOR FACIAL SOFT TISSUE APPROVAL - September 29, 2005
NEW STUDY CONFIRMS RADIESSE INJECTABLE FILLER PROVIDES LONG-TERM IMPROVEMENT OF VOCAL FOLD INSUFFICIENCY: New Generation Augmentation Treatment Offers Renewed Hope for Patients Suffering from Common Voice-Altering Conditions